CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...